AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on substance use disorders from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on substance use disorders from PolicyFinder
Mature patient talking with psychotherapist in an office

Care for substance use disorder guide

Updated
| 3 Min Read
Clear Search
·
5 Min Read

Access to treatment is key in addressing drug-overdose epidemic

Learn what’s driving inequities in the drug-overdose epidemic and why giving patients proven treatments is more effective than incarceration.

Behavioral Health
·
15 Min Read

Shifting the conversation about substance use disorder with Bobby Mukkamala, MD

AMA's Moving Medicine series features physician voices and achievements. Learn more in this discussion with Bobby Mukkamala, MD, on substance use disorder.

series
Behavioral Health
Moving Medicine Video Update
·
4 Min Read

April 1, 2022: Advocacy Update other news

Upcoming webinars on the overdose epidemic and out-of-network payment process and more in the latest Advocacy Update other news.

Advocacy Update
Person in grocery aisle
·
4 Min Read

Removing naloxone’s Rx status is an essential step to save lives

As the drug-overdose epidemic worsens, there is no moral, medical or safety-related reason for keeping naloxone locked under prescription regulations.

Behavioral Health
Stethoscope draping a red toolkit
·
4 Min Read

Toolkit packed with evidence to help end drug-overdose epidemic

Some state officials are leading the way with science-driven policy that saves lives. It’s time their colleagues follow suit. Learn more with the AMA.

Behavioral Health
·
3 Min Read

Feb. 18, 2022: State Advocacy Update

New toolkit highlights effective policies in combating drug overdoses and more in the latest State Advocacy Update.

Advocacy Update
·
2 Min Read

AMA urges Administration to remove naloxone from behind the counter

Removing the prescription status of naloxone as an essential step to save lives from opioid-related overdose, helps to make naloxone available to patients.

Press Releases
·
2 Min Read

AMA welcomes draft CDC changes in opioid guidance

The AMA applauds the CDC for acknowledging the original guideline missed the mark.

Press Releases
·
3 Min Read

AMA, Manatt Health unveil toolkit to combat drug overdoses

The AMA and Manatt Health release a toolkit to guide states on removing barriers to evidence-based patient care.

Press Releases